l carnitine tmao koeth 2013 nature medicine

l carnitine tmao koeth 2013 nature medicine Revisiting the Role of in Heart Disease Through the Lens of the Gut Microbiota γ–Butyrobetaine is a pro-atherogenic intermediate

Name: l carnitine tmao koeth 2013 nature medicine Revisiting the Role of in Heart Disease Through the Lens of the Gut Microbiota γ–Butyrobetaine is a pro-atherogenic intermediate
Brand: lagence-mr.com
SKU: 38510749857
Price: 24.08 USD
Availability: InStock
Rating: 4.2169 (30 reviews)

Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Gut Derived Metabolite, Trimethylamine N oxide (TMAO) in Cardio Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link

SKU: 38510749857 · From lagence-mr.com

4.2

USD24.08 USD73.08

Pay in 4 interest-free payments of $6.02 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

Administration of recombinant GHRH for 3 months reduces abdominal visceral fat mass and icnreases physical performance measures in postmenopausal women